The DOI matches its Crossref record; 63 of the 73 references it cites were found in a registry or an index.
DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2
Open accessAbstract
DNA-damaging agents signal to p53 through as yet unidentified posttranscriptional mechanisms. Here we show that phosphorylation of human p53 at serine 15 occurs after DNA damage and that this leads to reduced interaction of p53 with its negative regulator, the oncoprotein MDM2, in vivo and in vitro. Furthermore, using purified DNA-dependent protein kinase (DNA-PK), we demonstrate that phosphorylation of p53 at serines 15 and 37 impairs the ability of MDM2 to inhibit p53-dependent transactivation. We present evidence that these effects are most likely due to a conformational change induced upon phosphorylation of p53. Our studies provide a plausible mechanism by which the induction of p53 can be modulated by DNA-PK (or other protein kinases with similar specificity) in response to DNA damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Doxorubicin treatment of early passage tumor cell lines revealed that five of five early generation mTerc Ink4a / Arf -/ -tumors maintained intact p53 response evidenced by p53 Ser-18 phosphorylation (37, 38) and associated induction of p21 CIP1 .”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [37]
In the citing paper
“Induction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to the rapid stabilization of p53 through phosphorylation of its N terminus (Shieh et al. 1997; Siliciano et al. 1997”
From p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis (1999) · cites this paper as Shieh et al. 1997
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on serine 20 and inhibits MDM2 binding (Shieh et al, 1997;Banin et al, 1998;Chehab et al, 2000;Shieh et al, 2000).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Shieh et al, 1997
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on S20, which is a part of the MDM2-binding site (Shieh et al, 1997(Shieh et al, , 2000;;Banin et al, 1998;Chehab et al, 2000).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Shieh et al, 1997
In the citing paper
“Several landmark studies showed that DNA double strand breaks induce phosphorylation of p53 S15 by DNA-PK and ATM (Mayo et al, 1997;Shieh et al, 1997;Banin et al, 1998;Prives and Hall, 1999).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Shieh et al, 1997
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Self-citationStructure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474
Research works printed but not linked: 3
- Hawley, 1996, Stange bedfellows in even stranger places, Genes Dev., 10, 1383
- Meek, 1994, Posttranslational modification of p53, Semin. Cancer Biol., 5, 203
- Nelson, 1994, DNA strand breaks, Mol. Cell. Biol., 14, 1815
Cited by
Sorted by citations
Items 901–1,000 of 1,005
Activation of DNA‐Dependent Protein Kinase May Play a Role in Apoptosis of Human Neuroblastoma Cells
Chakravarthy, B. R., Walker, T., Rasquinha, I., Hill, I. E., & MacManus, J. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720933.x · Cited by 44
Tian, F., Nakahara, T., Yoshida, M., Honda, N., Hirose, H., & Miyakoshi, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6661 · Cited by 46
Gatti, L., Supino, R., Perego, P., Pavesi, R., Caserini, C., Carenini, N., Righetti, S. C., Zuco, V., & Zunino, F. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401109 · Cited by 45
Nemajerová, A., Erster, S. H., & Moll, U. M. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401526 · Cited by 44
Jabbur, J. R., Tabor, A., Cheng, X., Wang, H., Uesugi, M., Lozano, G., & Zhang, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205856 · Cited by 46
Suda, K., Moriyama, Y., Razali, N., Chiu, Y., Masukagami, Y., Nishimura, K., Barbee, H., Takase, H., Sugiyama, S., Yamazaki, Y., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00575-6 · Cited by 43
White, E. A., Walther, J., Javanbakht, H., & Howley, P. M. (2014) · Journal of Virology · doi:10.1128/jvi.01197-14 · Cited by 43
The Role of MDM2 in Promoting Genome Stability versus Instability
Saadatzadeh, M. R., Elmi, A. N., Pandya, P. H., Bijangi‐Vishehsaraei, K., Ding, J., Stamatkin, C. W., Cohen‐Gadol, A., & Pollok, K. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102216 · Cited by 44
IL-24 Promotes Apoptosis through cAMP-Dependent PKA Pathways in Human Breast Cancer Cells
Persaud, L., Mighty, J., Zhong, X., Francis, A., Mendez, M., Muharam, H., Redenti, S., Das, D. K., Aktas, B. H., & Sauane, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113561 · Cited by 43
Ghazi, T., Nagiah, S., & Chuturgoon, A. A. (2020) · Epigenetics · doi:10.1080/15592294.2020.1788324 · Cited by 43
Mitochondrial–nuclear p53 trafficking controls neuronal susceptibility in stroke
Almeida, Á., Sánchez‐Morán, I., & Rodríguez, C. (2021) · IUBMB Life · doi:10.1002/iub.2453 · Cited by 43
Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
Loh, D., & Reiter, R. J. (2021) · Antioxidants · doi:10.3390/antiox10091483 · Cited by 45
Association of p53 with Neurodegeneration in Parkinson’s Disease
Luo, Q., Sun, W., Wang, Y., Li, J., & Li, D.-W. (2022) · Parkinson s Disease · doi:10.1155/2022/6600944 · Cited by 44
Inoue, T. M., Geyer, R. K., Yu, Z. K., & Maki, C. G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02123-8 · Cited by 43
Melatonin Induces Apoptotic Cell Death via p53 in LNCaP Cells
Kim, C. H., & Yoo, Y. (2010) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2010.14.6.365 · Cited by 43
Gewandter, J. S., Bambara, R. A., & O’Reilly, M. A. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16347 · Cited by 44
Fox, J. T., Shin, W. K., Caudill, M. A., & Stover, P. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.015800 · Cited by 43
Ishii, N., Matsumura, T., Kinoshita, H., Motoshima, H., Kojima, K., Tsutsumi, A., Kawasaki, S., Yano, M., Senokuchi, T., Asano, T., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028043 · Cited by 43
Minsavage, G. D., & Dillman, J. F. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116145 · Cited by 43
Kim, Y., Chongviriyaphan, N., Liu, C., Russell, R. M., & Wang, X.-D. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi340 · Cited by 43
Ferrigno, P. K., & Silver, P. A. (1999) · Oncogene · doi:10.1038/sj.onc.1203132 · Cited by 43
Haynes, R. L. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00476-2 · Cited by 43
Keramaris, E., Hirao, A., Slack, R. S., Mak, T. W., & Park, D. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304049200 · Cited by 43
Loss of hepatocyte cell division leads to liver inflammation and fibrosis
Dewhurst, M. R., Ow, J. R., Zafer, G., van Hul, N. K. M., Wollmann, H., Bisteau, X., Brough, D., Choi, H., & Kaldis, P. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1009084 · Cited by 42
Long, Y., Wang, W., Zhang, Y., Du, F., Zhang, S., Li, Z., Deng, J., & Li, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076120 · Cited by 42
Macedo‐Silva, C., Miranda‐Gonçalves, V., Tavares, N. T., Barros‐Silva, D., Lencart, J., Lobo, J., de Oliveira, Â. G. N., Correia, M. P., Altucci, L., & Jerónimo, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01639-6 · Cited by 42
Oncogene-mediated regulation of p53 ISGylation and functions
Huang, Y., & Bulavin, D. V. (2014) · Oncotarget · doi:10.18632/oncotarget.2199 · Cited by 42
Altered Binding Site Selection of p53 Transcription Cassettes by Hepatitis B Virus X Protein
Chan, C. S. C., Wang, Y., Chow, P. K. H., Chung, A. Y. F., Ooi, L. L., & Lee, C. G. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01189-12 · Cited by 42
An, W. G., Chuman, Y., Fojo, T., & Blagosklonny, M. V. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4193 · Cited by 42
A Defect in the p53 Response Pathway Induced by de Novo Purine Synthesis Inhibition
Bronder, J. L., & Moran, R. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304844200 · Cited by 42
PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells
Davies, L., Spiller, D. G., White, M., Grierson, I., & Paraoan, L. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.19 · Cited by 42
Nakajima, Y., Nagai, K., Miyaké, S., Ohashi, K., Kawano, T., & Iwai, T. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb02173.x · Cited by 42
Mönke, G., Cristiano, E., Finzel, A., Friedrich, D., Herzel, H., Falcke, M., & Loewer, A. (2017) · Scientific Reports · doi:10.1038/srep46571 · Cited by 44
Protection of normal human reconstructed epidermis from UV by catalase overexpression
Rezvani, H. R., Cario, M., Pain, C., Ged, C., deVerneuil, H., & Taı̈eb, A. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701000 · Cited by 42
Dan, S., & Yamori, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4231 · Cited by 42
Zhang, G., Park, M. A., Mitchell, C., Walker, T. D., Hamed, H. A., Studer, E. J., Graf, M. R., Rahmani, M., Gupta, S., Hylemon, P. B., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803444200 · Cited by 42
Fricke, E., Keller, G., Becker, I., Rosivatz, E., Schott, C., Plaschke, S., Rudelius, M., Hermannstädter, C., Busch, R. M., Höfler, H., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10879 · Cited by 42
Furuta, S., ORTIZ, F., Sun, X. Z., Wu, H., Mason, A. Z., & Momand, J. A. (2002) · Biochemical Journal · doi:10.1042/bj20011251 · Cited by 42
Lee, S. S., Vũ, T. T., Weiss, A. S., & Yeo, G. C. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151331 · Cited by 43
Garufi, A., Ubertini, V., Mancini, F., D’Orazi, V., Baldari, S., Moretti, F., Bossi, G., & D’Orazi, G. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0206-x · Cited by 41
Suzuki, M., Suzuki, K., Kodama, S., & Watanabe, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.167 · Cited by 42
p53 Requires the Stress Sensor USF1 to Direct Appropriate Cell Fate Decision
Bouafia, A., Corre, S., Gilot, D., Mouchet, N., Prince, S., & Galibert, M. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004309 · Cited by 45
A high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization
Xu, G. W., Mawji, I. A., Macrae, C. J., Koch, C. A., Datti, A., Wrana, J. L., Dennis, J. W., & Schimmer, A. D. (2008) · APOPTOSIS · doi:10.1007/s10495-007-0175-4 · Cited by 41
SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways
Gubanova, E., Issaeva, N., Göktürk, C., Djureinovic, T., & Helleday, T. (2013) · Cell Cycle · doi:10.4161/cc.26660 · Cited by 41
A small molecule inhibitor of p53-inducible protein phosphatase PPM1D
Yagi, H., Chuman, Y., Kozakai, Y., Imagawa, T., Takahashi, Y., Yoshimura, F., Tanino, K., & Sakaguchi, K. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.084 · Cited by 41
Vidal-Cardenas, S. L., & Greider, C. W. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp855 · Cited by 41
Zhao, B., Chen, H., Du, X., Luo, J., He, J., Wang, R., Wang, Y., Wu, R., Hou, R.-R., Hong, M., et al. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0081 · Cited by 41
COX inhibitors directly alter gene expression: role in cancer prevention?
Wang, X., Baek, S. J., & Eling, T. E. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9301-4 · Cited by 41
Nakamura, Y. (1998) · Nature Medicine · doi:10.1038/3207 · Cited by 41
Analysis of JNK, Mdm2 and p14ARF contribution to the regulation of mutant p53 stability
Buschmann, T., Minamoto, T., Wagle, N., Fuchs, S. Y., Adler, V., Mai, M., & Ronai, Z. A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3387 · Cited by 41
SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle
Lu, Y.-F., Xu, X.-P., Lu, X.-P., Zhu, Q., Liu, G., Bao, Y.-T., Wen, H., Li, Y.-L., Gu, W., & Zhu, W.-G. (2020) · Oncogene · doi:10.1038/s41388-020-1305-5 · Cited by 40
Guarducci, C., Nardone, A., Russo, D., Nagy, Z., Héraud, C., Grinshpun, A., Zhang, Q., Freelander, A., Leventhal, M. J., Feit, A. S., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2975 · Cited by 41
Fiore, R. D., Marcatti, M., Drago‐Ferrante, R., D’Anneo, A., Giuliano, M., Carlisi, D., BLASIO, A. D., Querques, F., Pastore, L., Tesoriere, G., et al. (2014) · Bone · doi:10.1016/j.bone.2013.12.021 · Cited by 40
Maternal Embryonic Leucine Zipper Kinase (MELK) Reduces Replication Stress in Glioblastoma Cells
Kığ, C., Beullens, M., Beke, L., Eynde, A. V., Linders, J. T., Brehmer, D., & Bollen, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.471433 · Cited by 40
RetractedAraki, R., Fukumura, R., Fujimori, A., Taya, Y., Shiloh, Y., Kurimasa, A., Burma, S., Li, G. C., Chen, D. J., Sato, K., et al. (1999) · PubMed · Cited by 40
Self-citationHobom, U., & Dobbelstein, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7685-7697.2004 · Cited by 40
Gesser, B., Rasmussen, M. K., Raaby, L., Rosada, C., Johansen, C., Kjellerup, R. B., Kragballe, K., & Iversen, L. (2011) · Inflammation Research · doi:10.1007/s00011-011-0316-7 · Cited by 40
Ku70/80 Modulates ATM and ATR Signaling Pathways in Response to DNA Double Strand Breaks
Tomimatsu, N., Tahimic, C. G. T., Otsuki, A., Burma, S., Fukuhara, A., Sato, K., Shiota, G., Oshimura, M., Chen, D. J., & Kurimasa, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611880200 · Cited by 42
Identification and Analysis of a Hyperactive Mutant Form of Drosophila P-Element Transposase
Beall, E. L., Mahoney, M. B., & Rio, D. C. (2002) · Genetics · doi:10.1093/genetics/162.1.217 · Cited by 40
Oguchi, K. (2003) · Blood · doi:10.1182/blood-2002-02-0570 · Cited by 40
Dip, R., & Naegeli, H. (2005) · The FASEB Journal · doi:10.1096/fj.04-3041rev · Cited by 40
Rubin de Celis, M. F., Garcia-Martin, R., Syed, I., Lee, J., Aguayo-Mazzucato, C., Bonner-Weir, S., & Kahn, B. B. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206923119 · Cited by 39
Mechanisms of Biological Effects of Ionic Liquids: From Single Cells to Multicellular Organisms
Egorova, K. S., Кибардин, А. В., Posvyatenko, A. V., & Ananikov, V. P. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00420 · Cited by 40
Control of p53 nuclear accumulation in stressed cells
Inoue, T. M., Wu, L., Stuart, J., & Maki, C. G. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.006 · Cited by 40
Hu, L., Wang, J., Liu, Y., Zhang, Y., Zhang, L., Kong, R., Zheng, Z., Du, X., & Ke, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.157842 · Cited by 41
Hollomon, M. G., Gordon, N. B., Santiago‐O’Farrill, J. M., & Kleinerman, E. S. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-500 · Cited by 42
Choi, H. S., Seo, H., Kim, J. H., Um, J., Shin, Y. C., & Ko, S. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-82 · Cited by 39
Sidhar, H., & Giri, R. K. (2017) · Scientific Reports · doi:10.1038/srep41420 · Cited by 41
Xu, X., Liu, A., Bai, Y., Li, Y., Zhang, C., Cui, S., Piao, Y., & Zhang, S. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.05.008 · Cited by 39
MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner
Liu, B., Yi, J., Yang, X. P., Liu, L., Lou, X., Zhang, Z., Qi, H., Wang, Z., Zou, J., Zhu, W., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0605-5 · Cited by 39
Intracellular partners of fibroblast growth factors 1 and 2 - implications for functions
Służalska, K. D., Sławski, J., Sochacka, M., Lampart, A., Otlewski, J., & Zakrzewska, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.004 · Cited by 40
Albert, E., & Laimins, L. A. (2020) · Viruses · doi:10.3390/v12070744 · Cited by 41
Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma
Kumar, D., Das, M., Oberg, A., Sahoo, D., Wu, P., Sauceda, C., Jih, L., Ellies, L. G., Langiewicz, M., Sen, S., et al. (2022) · Advanced Science · doi:10.1002/advs.202105120 · Cited by 39
Dreyfus, D. H., Nagasawa, M., Gelfand, E. W., & Ghoda, L. Y. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-12 · Cited by 39
Seo, S., Lee, H., Woo, S., Jin, H., Yoo, D., Lee, S., An, S., Choe, T., Park, M., Hong, S., et al. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0527-5 · Cited by 39
Tumor suppressor genes in breast cancer.
Oesterreich, S., & Fuqua, S. A. W. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060405 · Cited by 39
Valli, C., Paroni, G., Francesco, A. M. D., Riccardi, R., Tavecchio, M., Erba, E., Boldetti, A., Gianni’, M., Fratelli, M., Pisano, C., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0419 · Cited by 39
Boutell, C., & Everett, R. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8068-8077.2004 · Cited by 42
ATM: the product of the gene mutated in ataxia-telangiectasia
Lavin, M. F. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00028-x · Cited by 39
Jack, M. T., Woo, R. A., Motoyama, N., Takai, H., & Lee, P. W. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309917200 · Cited by 39
Li, Z., Musich, P. R., Serrano, M. A., Dong, Z., & Zou, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028326 · Cited by 38
Kanemitsu, H., Yamauchi, H., Komatsu, M., Yamamoto, S., Okazaki, S., Uchida, K., & Nakayama, H. (2008) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2008.10.001 · Cited by 39
RECQL4 Regulates p53 Function In Vivo During Skeletogenesis
Lu, L., Harutyunyan, K. G., Jin, W., Wu, J., Yang, T., Chen, Y., Joeng, K. S., Bae, Y., Tao, J., Dawson, B., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2436 · Cited by 39
Cellular adaptation to hypoxia and p53 transcription regulation
Zhao, Y., Chen, X., & Du, J.-Z. (2009) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b0820293 · Cited by 39
Baydoun, H. H., Pancewicz, J., & Nicot, C. (2011) · Blood · doi:10.1182/blood-2010-08-304600 · Cited by 38
Milošević, J., Schwarz, S. C., Ogunlade, V., Meyer, A. K., Storch, A., & Schwarz, J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-25 · Cited by 38
SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line
Ninković, D. S., Petrović, I., Vuković, V., Schwirtlich, M., Gredic, M., Stevanović, M. J., & Popovic, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184686 · Cited by 38
Qiu, X., Liu, Y., Zhang, Y., Guan, Y., Jia, Q., Wang, C., He, L., Li, Y., Yang, H., Qin, Y., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005295 · Cited by 38
Granata, C., Oliveira, R. S. F., Little, J. P., & Bishop, D. J. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00233.2019 · Cited by 39
Huang, X., Zhang, S., Qi, H., Wang, Z., Chen, H.-W., Shao, J., & Shen, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.05.026 · Cited by 38
Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice
Naka, K. Κ., Vezyraki, P., Kalaitzakis, A., Zerikiotis, S., Michalis, L. K., & Angelidis, C. E. (2014) · Cell Stress and Chaperones · doi:10.1007/s12192-014-0509-4 · Cited by 38
Liu, W., Ip, M. M., Podgorsak, M. B., & Das, G. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0044-z · Cited by 38
HPV 16 E6 Blocks TNF-Mediated Apoptosis in Mouse Fibroblast LM Cells
Duerksen-Hughes, P. J., Yang, J. J., & Schwartz, S. B. (1999) · Virology · doi:10.1006/viro.1999.9977 · Cited by 38
MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis
Mancini, F., Gentiletti, F., D'Angelo, M., Giglio, S., Nanni, S., D’Angelo, C., Farsetti, A., Citro, G., Sacchi, A., Pontecorvi, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311793200 · Cited by 38
McLaughlin, L. M., & Demple, B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4254 · Cited by 38
Rodrigo, G., Roumagnac, S., Wold, M. S., Salles, B., & Calsou, P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2696-2705.2000 · Cited by 38
Dysregulation of cellular membrane homeostasis as a crucial modulator of cancer risk
Erazo‐Oliveras, A., Muñoz‐Vega, M., Salinas, M. L., Wang, X., & Chapkin, R. S. (2022) · FEBS Journal · doi:10.1111/febs.16665 · Cited by 38
Pei, J., Park, I.-H., Ryu, H., Li, S.-Y., Li, C., Lim, S.-H., Wen, M., Jang, W., & Jung, S. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0475-8 · Cited by 37
Paulitschke, V., Berger, W., Paulitschke, P., Hofstätter, E., Knapp, B., Dingelmaier‐Hovorka, R., Födinger, D., Jäger, W. R., Szekeres, T., Meshcheryakova, A., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0701 · Cited by 38
Widespread Overexpression of Epitope-Tagged Mdm4 Does Not Accelerate Tumor Formation In Vivo
De Clercq, S., Gembarska, A., Denecker, G., Maetens, M., Naessens, M., Haigh, K., Haigh, J. J., & Marine, J.-C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00330-10 · Cited by 35
Metadata
- Authors
- Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C.
- Affiliations
- Columbia University (US)
- Medical & Biological Laboratories (Japan) (JP)
- National Cancer Center Research Institute (JP)
- Corresponding author
- Prives, Carol
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1997-10
- Volume
- 91
- Issue
- 3
- Pages
- 325-334
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W1978518304
- Cited by
- 2,100
- References
- 73
- Citations by year
- 2026: 15 · 2025: 25 · 2024: 40 · 2023: 53 · 2022: 72 · 2021: 53 · 2020: 49 · 2019: 45 · 2018: 47 · 2017: 72 · 2016: 50 · 2015: 55 · 2014: 74 · 2013: 86 · 2012: 84
- FWCI
- 45.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 58316)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, DNA damage response, DNA-dependent protein kinase, p53-MDM2 interaction, protein conformational change
- MeSH terms
- Binding Sites, DNA Damage, DNA-Binding Proteins, Humans, Nuclear Proteins, Phosphorylation, Proto-Oncogene Proteins, Serine, Tumor Cells, Cultured, Transcriptional Activation, Down-Regulation, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review